Category: Published Articles
-

A Rare Case of Hypothyroidism, Type 1 Diabetes Mellitus, and Systemic Lupus Erythematosus with Immunosuppressive Consequences
Introduction Autoimmune diseases often present in complex and overlapping patterns, making diagnosis and management a challenge. This case study highlights a rare coexistence of Systemic Lupus Erythematosus (SLE), Type 1 Diabetes Mellitus (T1DM), and Hypothyroidism, with immunosuppressive therapy leading to opportunistic infections. The interplay of these conditions presents significant clinical implications. Visit HSPIOA for more…
-

Familial Hypocalciuric Hypercalcemia A Rare but Important Cause of Persistent Hypercalcemia
Introduction: Familial Hypocalciuric Hypercalcemia (FHH) is a rare, inherited disorder that often presents as asymptomatic hypercalcemia. Unlike primary hyperparathyroidism, FHH is usually benign, requiring minimal or no treatment. This article provides a detailed overview of FHH, including its genetic causes, clinical presentation, diagnosis, and management. Visit HSPIOA for more groundbreaking research in this field. What…
-

Atypical Anti-GBM with ANCA Vasculitis A Rare and Challenging Case from Eastern India
Introduction: Atypical Anti-Glomerular Basement Membrane (GBM) disease with concurrent ANCA vasculitis is an extraordinarily rare medical entity, with only a handful of reported cases worldwide. This case study, originating from India, sheds light on the complexities of diagnosing and managing such cases. Visit HSPIOA for more groundbreaking research in nephrology. Case Overview: A 33-year-old woman…
-

Successful Long-Term Tolvaptan Therapy in a Patient with Enlarged Polycystic Kidneys A Case Study
Introduction Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a progressive condition characterized by the enlargement of cystic kidneys and declining renal function. Tolvaptan, a vasopressin V2 receptor antagonist, is widely used to slow this progression. This case study examines an ADPKD patient with significantly enlarged kidneys who responded positively to long-term Tolvaptan therapy. Visit HSPIOA…
-

Long-Term Efficacy of Tolvaptan in Managing Enlarged Polycystic Kidneys A Case Study
Introduction Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a progressive condition characterized by kidney enlargement and declining renal function. A recent case study highlights the long-term efficacy of tolvaptan, a vasopressin V2 receptor antagonist, in stabilizing kidney size and function in a patient with markedly enlarged polycystic kidneys. Visit HSPIOA for more groundbreaking research in…
-

Renal Lymphangiectasia A Rare Diagnostic and Therapeutic Challenge
Introduction:Renal lymphangiectasia is a rare lymphatic disorder characterized by cystic infiltration in the perirenal and para-pelvic spaces due to lymphatic drainage defects. Misdiagnosis is common due to its similarity to other renal cystic conditions. This case report highlights a pediatric case of renal lymphangiectasia, detailing the diagnostic and therapeutic challenges associated with the condition. Visit…
-

Balancing Thrombosis and Infection Risks
Introduction The duration of no-tunneled hemodialysis catheters (NTHCs) significantly influences patient outcomes, particularly regarding thrombosis and infection risks. This study, published in the Journal of Clinical Nephrology, investigates the ideal residence time for temporary central venous catheters (CVCs) and its impact on complications. Visit HSPIOA for more groundbreaking research in nephrology and dialysis access. Key…
-

Reducing Exit-Site Infections in Peritoneal Dialysis The Role of Silver-Based Dressings
Introduction Peritoneal dialysis (PD) is a widely used home-based renal replacement therapy for patients with end-stage renal disease (ESRD). However, infections at the peritoneal catheter exit site remain a significant challenge. Recent research explores the role of silver ion-releasing dressings (Exit-Pad Ag) in reducing exit-site infections and preventing the transition from PD to hemodialysis. Visit…
-

Porphyria Cutanea Tarda in a Hemodialysis Patient Following Kidney Transplant Rejection A Rare Case Report
Introduction Porphyria Cutanea Tarda (PCT) is a rare metabolic disorder of heme biosynthesis characterized by skin fragility, blisters, and hyperpigmentation. While PCT is uncommon in dialysis patients, it can occur due to iron overload, chronic kidney disease, and environmental triggers like alcohol and smoking. This case report presents a 40-year-old man with PCT following kidney…
-

Innovative Therapies for Liver Failure Management
Introduction Extracorporeal Blood Purification Therapies (EBPTs) have evolved beyond their initial use in renal support and are now being explored for liver failure treatment. These therapies aim to remove toxins, inflammatory mediators, and excess fluids, improving patient outcomes in acute and chronic liver diseases. Visit Journal of Clinical Nephrology for more groundbreaking research on extracorporeal…
